Literature DB >> 28988749

Peptide therapeutics from venom: Current status and potential.

Michael W Pennington1, Andrzej Czerwinski2, Raymond S Norton3.   

Abstract

Peptides are recognized as being highly selective, potent and relatively safe as potential therapeutics. Peptides isolated from the venom of different animals satisfy most of these criteria with the possible exception of safety, but when isolated as single compounds and used at appropriate concentrations, venom-derived peptides can become useful drugs. Although the number of venom-derived peptides that have successfully progressed to the clinic is currently limited, the prospects for venom-derived peptides look very optimistic. As proteomic and transcriptomic approaches continue to identify new sequences, the potential of venom-derived peptides to find applications as therapeutics, cosmetics and insecticides grows accordingly.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2017        PMID: 28988749     DOI: 10.1016/j.bmc.2017.09.029

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  57 in total

1.  Tentacle Transcriptomes of the Speckled Anemone (Actiniaria: Actiniidae: Oulactis sp.): Venom-Related Components and Their Domain Structure.

Authors:  Michela L Mitchell; Gerry Q Tonkin-Hill; Rodrigo A V Morales; Anthony W Purcell; Anthony T Papenfuss; Raymond S Norton
Journal:  Mar Biotechnol (NY)       Date:  2020-01-24       Impact factor: 3.619

2.  The three-dimensional structure of an H-superfamily conotoxin reveals a granulin fold arising from a common ICK cysteine framework.

Authors:  Lau D Nielsen; Mads M Foged; Anastasia Albert; Andreas B Bertelsen; Cecilie L Søltoft; Samuel D Robinson; Steen V Petersen; Anthony W Purcell; Baldomero M Olivera; Raymond S Norton; Terje Vasskog; Helena Safavi-Hemami; Kaare Teilum; Lars Ellgaard
Journal:  J Biol Chem       Date:  2019-04-11       Impact factor: 5.157

3.  Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways.

Authors:  Helena Safavi-Hemami; Shane E Brogan; Baldomero M Olivera
Journal:  J Proteomics       Date:  2018-05-16       Impact factor: 4.044

4.  Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii.

Authors:  Alexandria S Senetra; Matthew R Necelis; Gregory A Caputo
Journal:  Pept Sci (Hoboken)       Date:  2020-03-31

Review 5.  Hormone-like conopeptides - new tools for pharmaceutical design.

Authors:  Ashlin Turner; Quentin Kaas; David J Craik
Journal:  RSC Med Chem       Date:  2020-09-24

Review 6.  Voltage-gated sodium channels: (NaV )igating the field to determine their contribution to visceral nociception.

Authors:  Andelain Erickson; Annemie Deiteren; Andrea M Harrington; Sonia Garcia-Caraballo; Joel Castro; Ashlee Caldwell; Luke Grundy; Stuart M Brierley
Journal:  J Physiol       Date:  2018-02-06       Impact factor: 5.182

7.  Heterogeneous-Backbone Foldamer Mimics of a Computationally Designed, Disulfide-Rich Miniprotein.

Authors:  Chino C Cabalteja; Daniel S Mihalko; W Seth Horne
Journal:  Chembiochem       Date:  2018-11-27       Impact factor: 3.164

8.  Structure and allosteric activity of a single-disulfide conopeptide from Conus zonatus at human α3β4 and α7 nicotinic acetylcholine receptors.

Authors:  Madhan Kumar Mohan; Nikita Abraham; Rajesh R P; Benjamin Franklin Jayaseelan; Lotten Ragnarsson; Richard J Lewis; Siddhartha P Sarma
Journal:  J Biol Chem       Date:  2020-03-31       Impact factor: 5.157

9.  Identification of Novel Toxin Genes from the Stinging Nettle Caterpillar Parasa lepida (Cramer, 1799): Insights into the Evolution of Lepidoptera Toxins.

Authors:  Natrada Mitpuangchon; Kwan Nualcharoen; Singtoe Boonrotpong; Patamarerk Engsontia
Journal:  Insects       Date:  2021-04-29       Impact factor: 2.769

Review 10.  Immunological Responses to Envenomation.

Authors:  Rachael Y M Ryan; Jamie Seymour; Alex Loukas; J Alejandro Lopez; Maria P Ikonomopoulou; John J Miles
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.